AU Stock MarketDetailed Quotes
PAB Patrys Ltd
- 0.008
- 0.0000.00%
20min DelayNot Open May 13 16:00 AET
16.46MMarket Cap-2666P/E (Static)
0.000High0.000Low0Volume0.000Open0.008Pre Close0.00Turnover0.01352wk High0.00%Turnover Ratio2.06BShares0.00652wk Low-0.003EPS TTM11.09MFloat Cap0.619Historical HighLossP/E (Static)1.39BShs Float0.004Historical Low-0.003EPS LYR0.00%Amplitude--Dividend TTM4.00P/B1Lot Size--Div YieldTTM
About Patrys Ltd Company
Patrys Ltd focuses on the development of natural human antibody-based therapies for the treatment of cancer. The company's product includes Deoxymab 3E10, PAT-SC1, PAT-DX1 PAT-DX1-NP, PAT-DX3, and PAT-LM1. Its main technology is Deoxymab 3E10, a DNA damage repair (DDR) antibody that penetrates live cell nuclei and inhibits key mechanisms of DNA repair in target cancer cells.
Company Profile
SymbolPAB
Company NamePatrys Ltd
Founded2006
MarketASX
Fiscal Year Ends06-30
AddressLevel 4, 100 Albert Road South Melbourne
CityMelbourne
CountryAustralia
Zip Code3205
Phone+61 396703273
Websitehttps://www.patrys.com
Company Executives
- Name
- Position
- Salary
- James Campbell
- Chief Executive Officer,Managing Director
- --
- Michael Stork
- Non-Executive Director,Interim Chairman
- --
- Charmaine Gittleson
- Non-Executive Director
- --
- Suzy Jones
- Non-Executive Director
- --
- Pamela M Klein
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
%Chg